Background
Methods
Objectives
FNA technique
Cytological evaluation
Variables
Statistics
Results
Diagnostic yield of EUS-FNA in IPMC and PDAC
IPMC with EUS-FNA (n = 8) | PDAC (n = 84) | IPMC without EUS-FNA (n = 14) |
P
| |
---|---|---|---|---|
Age | 71.0 (62.0–79.0) | 71.5 (48.0–86.0) | 72.0 (52.0–80.0) | 0.89 |
Sex (M:F) | 5:3 | 49:35 | 10:4 | 0.55 |
T-stagea (T1-T2/T3-T4) | 3/5 | 19/65 | 10/4 | 0.001 |
N-stagea (N0/N1) | 10/1 | 55/29 | 10/4 | 0.22 |
IPMC (n = 8) | PDAC (n = 84) |
P
| |
---|---|---|---|
Needle passes | 3.0 (1.0–5.0) | 2.0 (1.0–11.0) | 0.33 |
Puncture route (stomach:duodenum) | 6:2 | 44:40 | 0.27 |
Correct diagnosis (sensitivity) | 62.5% (5/8) | 92.9% (78/84) | 0.03 |
Adverse events | 0 | 0 | 1.00 |
IPMC with EUS-FNA (n = 8) | PDAC (n = 84) | IPMC without EUS-FNA (n = 14) |
P
| |
---|---|---|---|---|
Total recurrence, no (%) | 6 (75.0) | 47 (55.9) | 9 (64.3) | 0.51 |
Local recurrence, no (%) | 3 (37.5) | 15 (17.8) | 6 (42.8) | 0.06 |
Liver or Lung metastasis, no (%) | 2 (25.0) | 24 (28.5) | 3 (21.4) | 0.85 |
Lymph node metastasis, no (%) | 3 (37.5) | 9 (10.7) | 1 (7) | 0.07 |
Peritoneal dissemination, no (%) | 2 (25.0) | 18 (21.4) | 4 (28.5) | 0.82 |